A voluntary recall of the erectile dysfunction treatment, Edex (alprostadil for injection) was announced due to a defect in the crimp caps used in the manufacturing of the product lot. Endo announced ...
Endo is having a hard time. The Dublin-based company, which Tuesday reported a $3.34 billion loss for the fourth quarter, is recalling one lot of an erectile dysfunction drug that is injected directly ...
DUBLIN, Feb. 24, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc. based in Malvern, Pennsylvania, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback